This is yet another study that provides hard evidence of the alleged side effects of Topamax, about which the FDA has issued warnings on several occasions in the last four years.
(PRWEB) April 09, 2013
A study published in the medical journal Acta Neurologica Scandinavica suggests a link between epilepsy drug Topamax and birth defects in newborns,* reports the Rottenstein Law Group, which is currently accepting clients in Topamax lawsuits and maintains a Topamax lawsuits page at http://www.rotlaw.com/topamax/.
The authors of the study, a group of Australian doctors, found a statistically significant relationship between a pregnant woman’s use of Topamax (topiramate) and the likelihood of hypospadias (genital defects) and brain defects in infants, according to the study.
“This is yet another study that provides hard evidence of the alleged side effects of Topamax, about which the FDA has issued warnings on several occasions in the last four years,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, referring to the American regulatory body’s Safety Alerts, including those that deal with developmental defects in infants.**
In 1996, the U.S. Food and Drug Administration approved Topamax, manufactured by Johnson & Johnson subsidiaries Ortho-McNeill and Noramco, Inc. In addition to epilepsy, the drug is also prescribed for Lennox-Gastaut syndrome, migraine headaches and bipolar disorder and to prevent weight gain for those on antidepressants. This is in addition to several other uses.
The Rottenstein Law Group encourages those who believe that they or their loved ones have suffered from the allegedly dangerous side effects of Topamax to visit the firm’s Topamax lawsuits page on its website. There, visitors can learn more about the drug and how to file a lawsuit.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com